Literature DB >> 2481226

Actions of pentobarbital enantiomers on nicotinic cholinergic receptors.

S H Roth1, S A Forman, L M Braswell, K W Miller.   

Abstract

The enantiomers of pentobarbital had four different actions on the nicotinic receptor-rich membranes from Torpedo electroplaques. (i) Both inhibited cholinergically stimulated cation flux through the receptor's channel, with IC50 values of approximately 25 microM and extremely weak stereoselectivity. (ii) (R)-(+)-[14C]Pentobarbital bound to a saturable site with an apparent dissociation constant of 100 microM, a Hill coefficient of 1.2, and a stoichiometry of 1:1 with the acetylcholine binding sites. (S)-(-)-Pentobarbital also displaced (+)-[14C]pentobarbital but its IC50 was 4-fold higher than that of the (+)-enantiomer under the same conditions. (iii) Both enantiomers caused a stereoselective allosteric inhibition of [3H]acetylcholine binding, which occurred over the same concentration range and with the same stereoselectivity as barbiturate binding. (iv) Above 1 mM, pentobarbital caused an unexpected and sudden increase in [3H]acetylcholine binding, which lacked significant stereoselectivity. These results are consistent with a model where low concentrations of pentobarbital act on the receptor by binding to allosteric sites that have higher affinity but lower stereoselectivity for the open channel conformation than for the resting conformation, whereas the highest concentrations of pentobarbital act by nonspecific mechanisms mediated by general membrane perturbations.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2481226

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  7 in total

Review 1.  General anaesthetic actions on ligand-gated ion channels.

Authors:  M D Krasowski; N L Harrison
Journal:  Cell Mol Life Sci       Date:  1999-08-15       Impact factor: 9.261

2.  Biphasic effect of pentobarbitone on chick myotube nicotinic receptor channel kinetics.

Authors:  G J Liu; B W Madsen
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

3.  Identifying barbiturate binding sites in a nicotinic acetylcholine receptor with [3H]allyl m-trifluoromethyldiazirine mephobarbital, a photoreactive barbiturate.

Authors:  Ayman K Hamouda; Deirdre S Stewart; David C Chiara; Pavel Y Savechenkov; Karol S Bruzik; Jonathan B Cohen
Journal:  Mol Pharmacol       Date:  2014-02-21       Impact factor: 4.436

Review 4.  Anesthetic sites and allosteric mechanisms of action on Cys-loop ligand-gated ion channels.

Authors:  Stuart A Forman; Keith W Miller
Journal:  Can J Anaesth       Date:  2011-01-07       Impact factor: 5.063

5.  Mechanisms of barbiturate inhibition of acetylcholine receptor channels.

Authors:  J P Dilger; R Boguslavsky; M Barann; T Katz; A M Vidal
Journal:  J Gen Physiol       Date:  1997-03       Impact factor: 4.086

6.  Inhibition of the nicotinic acetylcholine receptor by barbiturates and by procaine: do they act at different sites?

Authors:  C S Yost; B A Dodson
Journal:  Cell Mol Neurobiol       Date:  1993-04       Impact factor: 5.046

7.  Relative potencies for barbiturate binding to the Torpedo acetylcholine receptor.

Authors:  B A Dodson; R R Urh; K W Miller
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.